Stay updated on Daratumumab for Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Florida as a location in the Locations section and updated the page revision to v3.3.3; the older Florida Locations label and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:14:11.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.1 to v3.3.2. No substantive changes to the study details or page content are evident.
    Difference
    0.1%
    Check dated 2025-12-01T15:41:40.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision notes updated: added Revision: v3.3.1 and removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:47:04.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The government funding status notice was removed from the page; the study details and eligibility criteria remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:22:34.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page for NCT03477539; core study information remains unchanged. No alterations affecting eligibility criteria, outcomes, or locations are visible in this view.
    Difference
    0.4%
    Check dated 2025-11-03T01:04:45.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    3%
    Check dated 2025-10-05T09:28:08.000Z thumbnail image

Stay in the know with updates to Daratumumab for Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.